BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3239480)

  • 1. Histological reactions of human endometrium to the IUD.
    de Castro A; Contreras F
    Adv Contracept; 1988 Sep; 4(3):191-5. PubMed ID: 3239480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of high-load copper IUDs.
    de Castro A; Gonzalez-Gancedo P
    Adv Contracept; 1988 Sep; 4(3):185-90. PubMed ID: 3239479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of copper ions in vivo on specific hormonal endometrial receptors.
    de Castro A; Gonzalez-Gancedo P; Contreras F; Lapeña G
    Adv Contracept; 1986 Dec; 2(4):399-404. PubMed ID: 3551524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinicopathological study of IUD users with special reference to endometrial patterns and endometritis.
    van Bogaert LJ
    Gynecol Obstet Invest; 1983; 16(3):129-35. PubMed ID: 6618283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial morphological changes in IUD users: a review.
    Sheppard BL
    Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
    Wang IY; Russell P; Fraser IS
    Contraception; 1995 Apr; 51(4):243-8. PubMed ID: 7796590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher fibrinolytic activity in human endometrium in direct contact with an IUD.
    Liedholm P; Srivastava K; Wingerup L; Astedt B
    Acta Obstet Gynecol Scand; 1983; 62(2):169-70. PubMed ID: 6868967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of three copper IUDs (MLCu250, MLCu375 and Nova-T).
    Bratt H; Skjeldestad FE; Cullberg Valentin K
    Acta Obstet Gynecol Scand; 1988; 67(3):247-51. PubMed ID: 3051876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two copper IUDs: the MLCu375 and the Nova-T.
    de Castro A; Perez-Iglesias R; Vicandi F; Zapico A; Lopez-Salva A
    Adv Contracept; 1987 Dec; 3(4):319-22. PubMed ID: 3445799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use.
    Zhu P; Liu X; Luo H; Gu Z; Cheng J; Xu R; Lian S; Wu S; Wang J
    Hum Reprod; 1999 Apr; 14(4):970-5. PubMed ID: 10221229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrosion of filamentous intra-uterine copper. The MLCu250 and the MLCu375.
    Kosonen A; Thiery M
    Contraception; 1983 Jan; 27(1):85-93. PubMed ID: 6839762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Copper-IUD on the human endometrium (author's transl)].
    Tamaya T; Nakata Y; Nioka S; Obata T; Higashiyama S; Okada H
    Nihon Funin Gakkai Zasshi; 1978 Jan; 23(1):24-7. PubMed ID: 627299
    [No Abstract]   [Full Text] [Related]  

  • 16. Fifteen years' experience with the Multiload IUD.
    Van Os WA; Edelman DA
    Adv Contracept; 1988 Sep; 4(3):165-78. PubMed ID: 3071108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T.
    Andersson K; Batar I; Rybo G
    Contraception; 1992 Dec; 46(6):575-84. PubMed ID: 1493717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
    Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
    Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term clinical observation on VCu200 intrauterine devices].
    Wu XZ; Lu J; Li HQ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):545-7, 544-5. PubMed ID: 7835133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.